Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers

• Geraldine Perkins,

  Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Timothy A. Yap,

  Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  ⨯
• Lorna Pope,

  Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Amy M. Cassidy,

  Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Juliet P. Dukes,

  Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Ruth Riisnaes,

  Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Christophe Massard,

  Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  ⨯
• Philippe A. Cassier,

  Affiliation Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  ⨯
• Susana Miranda,

  Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Jeremy Clark,

  Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Katie A. Denholm,

  Affiliation Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  ⨯
• Khin Thway,

  Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• David Gonzalez De Castro,

  Affiliation Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom

  ⨯
• Gerhardt Attard,

  Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  ⨯
• L. Rhoda Molife,

  Affiliation Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  ⨯
• Stan B. Kaye,

  Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  ⨯
• Udai Banerji,

  Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  ⨯
•  [ ... ],
• Johann S. de Bono

  * E-mail: johann.de-bono@icr.ac.uk

  Affiliations Division of Clinical Studies, The Institute of Cancer Research, Sutton, Surrey, United Kingdom, Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom

  ⨯
• [ view all ]
• [ view less ]